An inhibitor of PNP
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

9-Deazaguanine

Item No. 21674

Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-amino-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one
CAS Number
65996-58-9
Synonyms
  • NSC 344522
Molecular Formula
C6H6N4O
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 2.5 mg/mlDMSO: 20 mg/mlDMSO:PBS(pH 7.2) (1:3): 0.25 mg/mlEthanol: slightly solublePBS (pH 7.2): slightly soluble
λmax
229, 260 nm
SMILES
NC(N1)=NC2=C(NC=C2)C1=O
InChi Code
InChI=1S/C6H6N4O/c7-6-9-3-1-2-8-4(3)5(11)10-6/h1-2,8H,(H3,7,9,10,11)
InChi Key
FFYPRJYSJODFFD-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    9-Deazaguanine is an analog of guanine that acts as an inhibitor of purine nucleoside phosphorylase (PNP; Kd = 160 nM).1 Inhibitors of PNP are used to control T cell proliferation, particularly in T cell cancers, autoimmune diseases, and tissue transplant rejection.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Wielgus-Kutrowska, B., Breer, K., Hashimoto, M., et alTrimeric purine nucleoside phosphorylase: Exploring postulated one-third-of-the-sites binding in the transition state. Bioorg. Med. Chem. 20(22), 6758-6769 (2012).

    2. Schramm, V.L. Development of transition state analogues of purine nucleoside phosphorylase as anti-T-cell agents. Biochim. Biophys. Acta 1587(2-3), 107-117 (2002).